Leukocyte Adhesion Deficiency Type II: Long-Term Follow-Up and Review of the Literature

被引:51
作者
Gazit, Yael [2 ]
Mory, Adi [5 ]
Etzioni, Amos [4 ,6 ]
Frydman, Moshe [3 ,7 ]
Scheuerman, Oded [1 ,3 ]
Gershoni-Baruch, Ruth [5 ,6 ]
Garty, Ben-Zion [1 ,2 ,3 ]
机构
[1] Schneider Childrens Med Ctr Israel, Dept Pediat B, IL-49202 Petah Tiqwa, Israel
[2] Schneider Childrens Med Ctr Israel, Kipper Inst Allergy & Immunol, IL-49202 Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Meyer Childrens Hosp, Div Immunol, Haifa, Israel
[5] Meyer Childrens Hosp, Div Genet, Haifa, Israel
[6] Technion Israel Inst Technol, Rappaport Sch Med, Haifa, Israel
[7] Chaim Sheba Med Ctr, Genet Inst, IL-52621 Tel Hashomer, Israel
关键词
Immunodeficiency; adhesion defects; selectins; fucose; neutrophilia; THERAPY; DEFECT;
D O I
10.1007/s10875-009-9354-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Leukocyte adhesion deficiency (LAD) is a group of rare inherited disorders characterized by immune deficiency and peripheral neutrophilia. There are only seven reported cases of LAD type II worldwide, and no long-term follow-up data. We reviewed the medical file of a 20-year-old man with LAD II. Clinical characteristics included short stature, severe mental retardation, and autistic features. He had had no severe infections since infancy, and his current immunological status was stable. The last laboratory work-up revealed mild leukocytosis and neutrophilia. Genetic analysis of the Golgi GDP-fucose transporter (GFTP) sequence yielded a point mutation resulting in Y337C amino acid transition in the tenth transmembrane domain. In conclusion, in LAD II, the main clinical countenance shifts from frequent infections due to immunodeficiency in the early years to the metabolic consequences of the defect in fucose metabolism, i.e., retarded growth and mental retardation, in the later years. A novel mutation in the GFTP loci associated with LAD II is described.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 23 条
[1]  
Aebi M, 1999, Glycoconj J, V16, P669
[2]   LAD-III, a novel group of leukocyte integrin activation deficiencies [J].
Alon, R ;
Etzioni, A .
TRENDS IN IMMUNOLOGY, 2003, 24 (10) :561-566
[3]  
Anderson D. C., 2001, METABOLIC MOL BASES, P4829
[4]   Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors [J].
Bauer, Thomas R., Jr. ;
Allen, James M. ;
Hai, Mehreen ;
Tuschong, Laura M. ;
Khan, Iram F. ;
Olson, Erik M. ;
Adler, Rima L. ;
Burkholder, Tanya H. ;
Gu, Yu-chen ;
Russell, David W. ;
Hickstein, Dennis D. .
NATURE MEDICINE, 2008, 14 (01) :93-97
[5]   Leukocyte adhesion deficiency type II: Long-term follow-up [J].
Etzioni, A ;
Gershoni-Baruch, R ;
Pollack, S ;
Shehadeh, N .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (02) :323-324
[6]   Fucose supplementation in leukocyte adhesion deficiency type II [J].
Etzioni, A ;
Tonetti, M .
BLOOD, 2000, 95 (11) :3641-3642
[7]   RECURRENT SEVERE INFECTIONS CAUSED BY A NOVEL LEUKOCYTE ADHESION DEFICIENCY [J].
ETZIONI, A ;
FRYDMAN, M ;
POLLACK, S ;
AVIDOR, I ;
PHILLIPS, ML ;
PAULSON, JC ;
GERSHONIBARUCH, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (25) :1789-1792
[8]   Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation [J].
Etzioni, A ;
Sturla, L ;
Antonellis, A ;
Green, ED ;
Gershoni-Baruch, R ;
Berninsone, PM ;
Hirschberg, CB ;
Tonetti, M .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 110 (02) :131-135
[9]   RAMBAM-HASHARON SYNDROME OF PSYCHOMOTOR RETARDATION, SHORT STATURE, DEFECTIVE NEUTROPHIL MOTILITY, AND BOMBAY PHENOTYPE [J].
FRYDMAN, M ;
ETZIONI, A ;
EIDLITZMARKUS, T ;
AVIDOR, I ;
VARSANO, I ;
SHECHTER, Y ;
ORLIN, JB ;
GERSHONIBARUCH, R .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 44 (03) :297-302
[10]  
Frydman M, 1996, PRENATAL DIAG, V16, P266, DOI 10.1002/(SICI)1097-0223(199603)16:3<266::AID-PD845>3.3.CO